AstraZeneca PLC
Close on Oct 19, 2026Market cap $255.76BP/E 25.1Yield 1.91%
AstraZeneca Other Vaccines & Immune Therapies by Year
Other Vaccines & Immune Therapies — Emerging Markets product sales ($M) ($M)
AstraZeneca Other Vaccines & Immune Therapies: $1M in FY2025, down 50.0% from a year earlier.
Where the FY2025 figure comes from
“|| Other V&I | 1 | (96) | (96) | - | n/m | 1 | (45) | (48) | - | n/m | n/m | - | n/m | n/m”
Source: Form 6-K FY2025Q4 Earnings Release ↗
Reported in Form 6-K / 20-F Product Sales Table.
Annual history
Hover a value to see the sentence it was read from; calculated values show their formula
| Period | Ended | Other Vaccines & Immune Therapies — Emerging Markets product sales ($M) ($M) | Year on year | Source |
|---|---|---|---|---|
| FY2025 | Dec 31, 2025 | 1 | -50.0% | Form 6-K FY2025Q4 Earnings Release ↗ |
| FY2024 | Dec 31, 2024 | 2 | – | Form 6-K FY2024Q4 Earnings Release ↗ |
Breakdown
What makes up other Vaccines & Immune Therapies
Cite this data
StockData. (2026). AstraZeneca Other Vaccines & Immune Therapies ($M), annual FY2024–FY2025 [Data set]. Compiled from AstraZeneca SEC filings and investor materials. https://stockdatahq.com/stocks/azn/kpis/med-other-vi-em
See every metric in the AstraZeneca KPI table. Data updated Oct 28, 2026.